← SynDRA
ETIZOLAM
SynDRA canonical compound SYN0024933 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | GABRA1 |
|---|
| Mechanism of action | Benzodiazepine receptor agonist |
|---|
| Indication | anxiety | insomnia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- GABRA1
- GABRA2
- GABRA3
- GABRA5
- GABRB2
- GABRB3
- GABRG2
- PTAFR
Mechanisms of action (all sources)
- Benzodiazepine receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- ESR1
- OPRK1
- ADORA1
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR3C1
- HRH2
- OPRD1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HRH3
- HRH1
- ADORA2A
- HDAC6
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ATAD5
- ESRRA
- GCR
- GLI3
- RARA
Drug classes
- Central Nervous System Agents
- Central Nervous System Depressants
- Psychotropic Drugs
- Tranquilizing Agents
ATC classes
Cross-references
Synonyms
- Y-7131
- depas
- AHR-3219
- Sedekopan
- DEA NO. 2780
- Depas
- Etizolamum
- A76XI0HL37
- DTXCID203030
- RefChem:596842
- N05BA19
- NCGC00182031-01
- Etizolam [INN:JAN]
- Etizolam (1.0 mg/mL in Methanol)
- Etizolamum [INN-Latin]
- AHR 3219
- BRN 0572740
- UNII-A76XI0HL37
- Sedekopan (TN)
- AHR3219;Y7131
- ETIZOLAM [INN]
- ETIZOLAM [JAN]
- ETIZOLAM [MI]
- Etizolam (JP18/INN)
- ETIZOLAM [MART.]
- ETIZOLAM [WHO-DD]
- SCHEMBL42920
- Etizolam, 1mg/ml in Methanol
- SCHEMBL30665015
- CHEBI:31583
- Etizolam 0.1 mg/ml in Methanol
- Etizolam 1.0 mg/ml in Methanol
- 4c66
- HMS3652N06
- HY-B0677
- Tox21_112931
- s4276
- AKOS022185397
Look up ETIZOLAM in the interactive SynDRA portal →